Intravenous Allogeneic Mesenchymal Stem Cell Therapy for Canine Immune ...
Abstract This study evaluates the clinical efficacy and safety of intravenous allogeneic mesenchymal stem cell (MSC) therapy as an adjunct to standard immunosuppressive treatment in dogs diagnosed with primary immune-mediated hemolytic anemia (IMHA), particularly in cases with inadequate response to conventional immunosuppressive protocols.
Three different dogs who had immune-mediated hemolytic anemia (IMHA) were treated for more than two weeks with blood transfusion in an animal clinic. Despite this treatment and hospitalization, there was no clinical improvement in clinical signs as well as complete blood cell count (CBC) including hematocrit (HCT) and C-reactive protein (CRP).
PDF Intravenous Allogeneic Mesenchymal Stem Cell Therapy for Canine Immune ...
This study evaluates the clinical efficacy and safety of intravenous allogeneic mesenchymal stem cell (MSC) therapy as an adjunct to standard immunosuppressive treatment in dogs diagnosed with primary immune-mediated hemolytic anemia (IMHA), particularly in cases with inadequate response to conventional immunosuppressive pro-tocols.
Allogenic Mesenchymal Stem Cell Therapy for IMHA in Dogs Current Therapies for Immune Mediated Hemolytic Anemia in Dogs Autoimmune disease treatment in dogs currently relies on the use of broad-spectrum immunosuppressive drugs, which are associated with unacceptable adverse effects in some patients.
Texas veterinarian saving anemic dogs through the use of stem cells
Texas veterinarian saving anemic dogs through the use of stem cells Stem cell therapy is a useful weapon in the fight against immune-mediated hemolytic anemia (IMHA) July 9, 2021 By Steven Garner, DVM, DABVP Derp, an eight-year-old Jack Russell terrier, was treated with stem cell therapy for his immune-mediated hemolytic anemia (IMHA).
Three different dogs who had immune-mediated hemolytic anemia (IMHA) were treated for more than two weeks with blood transfusion in an animal clinic. Despite this treatment and hospitalization, there was no clinical improvement in clinical signs as well as complete blood cell count (CBC) including hematocrit (HCT) and C-reactive protein (CRP). All cases were then injected two or three times ...
Stem Cell Treatment Through IV for Dogs with Immune
Mesenchymal stem cell (MSC) therapy may enhance recovery in dogs with primary immune-mediated hemolytic anemia (IMHA) who do not respond adequately to standard treatments. A total of 157 dogs were treated, and a core group of 43 met strict criteria for inclusion in the analysis.
Steroid-refractory immune-mediated hemolytic anemia (IMHA) in dogs carries high early mortality, and the 15%-30% of cases that fail corticosteroid-based therapy represent a population with few effective options and a narrowing treatment window. In a prior retrospective study, intravenous allogeneic …
Allogenic Mesenchymal Stromal Cells for the Treatment of Refractory ...
Autoimmune hemolytic anemia (AIHA) is a rare and challenging condition in dogs , characterized by immune-mediated destruction of red blood cells , leading to severe anemia . This case report describes the treatment of an 8-month-old dog with AIHA, which aims to evaluate the effectiveness of alternative therapies when conventional treatments fail.
